جست‌وجوی استاد و پژوهشگر

Indrani Bhattacharyaمشاهده پروفایل

استادیار

• Multimodal Machine Learning
• Medical Image Analysis
• Social Signal Processing
• +۳ مورد دیگر

Indrani Bhattacharya, PhD, is an Assistant Professor in the Department of Biomedical Data Science and the Center for Precision Health and Artificial Intelligence (CPHAI) at Dartmouth College's Geisel School of Medicine. Her research focuses on developing human-centered AI systems for healthcare, particularly in multimodal medical imaging and behavioral health analytics. She holds a BS in Electrical Engineering from Jadavpur University (India), and MS/PhD from Rensselaer Polytechnic Institute (USA). Postdoctoral training at Stanford University's Department of Radiology further specialized her in biomedical imaging informatics. Research interests include: Integrating imaging and non-imaging data for precision medicine AI-driven prostate cancer detection/classification Multimodal behavior estimation for doctor-patient interactions Privacy-preserving sensor systems for group interaction analysis Her work bridges computer vision, medicine, and social science, with recent breakthroughs in MRI-ultrasound fusion AI outperforming radiologist interpretations in multi-center studies. Active in AI ethics and translational research, she leads teams developing clinical decision support tools for oncology and behavioral health. Key career milestones include: Postdoctoral scholar at Stanford University School of Medicine (2016-2021) Academic research staff at Stanford Radiology (2021-2022) Founding member of Dartmouth CPHAI precision health initiatives Labs/Teams: Leads the Biomedical AI for Healthcare group at Dartmouth, collaborating with Stanford and industry partners on AI-driven diagnostic systems.

• Medical Education
• Primary Care
• Women in Medicine
• +۷ مورد دیگر

Rebecca Berman, MD , is a Professor in the School of Medicine at the University of California, San Francisco (UCSF) , where she serves as the Internal Medicine Residency Program Director. She plays a national leadership role in medical education and residency training reform. Education: AB in African-American Studies, Harvard College, 1999 MD, Harvard Medical School, 2005 Primary Care Internal Medicine Residency, Brigham and Women's Hospital, 2008 Diversity, Equity, and Inclusion Champion Training, UCSF, 2018 Research and Professional Interests: Dr. Berman’s work focuses on medical education , primary care innovation , diversifying the physician workforce , curricular design , negotiation skills training , women in medicine , and care for the underserved . She has pioneered initiatives to improve equity and leadership opportunities for underrepresented groups in medicine. Publication Trends: Her scholarly work spans over 15 years and includes key contributions to residency education, gender equity, health disparities (particularly in prostate cancer), and innovative teaching models. Recent publications emphasize pandemic recovery in medical training, bias reduction in residency selection, and leadership challenges for women in medicine. Scientific Awards and Honors: Inducted into the Haile T. Debas Academy of Medical Educators, UCSF (2022) Kanu Chatterjee, MD Medicine Residency Endowed Chair, UCSF (2024) Leadership and Teaching: Dr. Berman is a national leader in residency education, serving as a Councilor for the Association of Program Directors in Internal Medicine (APDIM), co-founding its Primary Care Program Director Group, and editing the widely used Primary Care Toolkit. She teaches negotiation skills to promote equity in academic medicine. She led the overhaul of UCSF’s internal medicine residency curriculum to enhance individualized training and resident well-being, especially during the pandemic. Labs and Teams: She founded the Crimson Care Collaborative (CCC) during her tenure at Harvard/Mass General, a student-faculty network providing primary care to underserved populations while offering interprofessional training. At UCSF, she leads one of the nation’s premier internal medicine residency programs, shaping the next generation of physicians.

Arnold I. Chinمشاهده پروفایل

استاد

• Urologic Oncology
• Renal Transplantation
• Cancer Stem Cell Research
• +۳ مورد دیگر

Dr. Arnold I. Chin is a Professor of Urology and Medical Director of Urology-Westwood at the David Geffen School of Medicine at UCLA. He completed both his MD and PhD at UCLA and completed his urology residency training there as well. His clinical expertise spans urologic oncology and renal transplantation, with specialization in open, laparoscopic, and robotic-assisted surgeries for bladder, kidney, and prostate cancer patients. Dr. Chin's educational background includes: MD, UCLA School of Medicine, 2003 PhD, UCLA, 2002 Internship in Surgery, UCLA School of Medicine, 2004 Residency in Urology, UCLA School of Medicine, 2009 Dr. Chin's research focuses on understanding cancer differentiation and its interplay with the tumor microenvironment. His laboratory investigates molecular mechanisms in programming tumor-infiltrating lymphocytes and mechanisms controlling development and differentiation of cancer stem cells. His work aims to develop novel therapeutic targets, immune-based platforms, and stem cell-directed therapies against cancer. He is affiliated with the Broad Stem Cell Research Center, Tumor Immunology Program Area, and Genitourinary Oncology Program Area of the Jonsson Comprehensive Cancer Center. His recent research has centered on bladder cancer, prostate cancer, renal cell carcinoma, and neuroendocrine carcinomas, with emphasis on tumor microenvironment, immunotherapy approaches, and molecular targets for cancer treatment. Dr. Chin has received several prestigious awards: Super Doctors® Southern California, 2022-2025 Super Doctors® Southern California Rising Stars 2018 STOP Cancer Research Career Development Award 2010 American Association of Cancer Research Career Development Award for Translational Cancer Research 2010 Dr. Chin is actively involved in mentoring students and research fellows in his laboratory, guiding them in cutting-edge cancer research. His work has been supported by various grants from organizations including STOP Cancer and the American Association of Cancer Research. He is also involved in clinical trials related to urologic cancers. Dr. Chin leads a translational research laboratory focused on tumor microenvironment in prostate and bladder cancer, using a combination of animal models, human reconstitution systems, and primary tumor and hematopoietic cells. His team is investigating molecular mechanisms in programming tumor-infiltrating lymphocytes and the development and differentiation of cancer stem cells.

• Prostate Cancer
• Cancer Biology
• Translational Research
• +۷ مورد دیگر

Professor Bill Watson is a Full Professor of Cancer Biology at the University College Dublin, School of Medicine , where he serves as Head of Pathology and Director of the Biomedical Health and Life Science BSc program. With a PhD in Biochemistry (University College Cork, 1995) and post-doctoral training at the University of Toronto, he has led translational research in prostate cancer since returning to UCD in 1997. His work focuses on biomarker discovery, therapy resistance mechanisms, and clinical decision tools through the Prostate Cancer Research Consortium and iPROSPECT collaborations. Education: BSc (University College Dublin), PhD (Royal College of Surgeons in Ireland), Post-Doctoral Research Fellow (Toronto General Hospital) His research integrates genomic, epigenetic, and proteomic biomarkers to improve prostate cancer stratification and treatment selection, as demonstrated in the Movember Global Action Plan and ToPCaP initiatives. Recent studies include validating a six-gene MCRS signature for biopsy-based prognostics (2025) and developing beta mixture models for DNA methylation analysis (2024). Scientific Awards include the Alton Prize (2000), Presidents Awards for Teaching (2000, 1998), and Young Investigator Award (1995). He has received grants such as the UCD Equip Scheme (2021) and Molecular Therapeutics for Cancer (2009-2015) . Professional Leadership: Irish Association for Cancer Research (President 2014-2017), Cancer Trials Ireland (Chair of Translational DSSG 2014-present), and Royal Academy of Medicine in Ireland (Fellow since 2006)

Vincenzo Della Meaمشاهده پروفایل

دانشیار

• Medical Informatics
• Digital Pathology
• Biomedical Ontologies
• +۳ مورد دیگر

Vincenzo Della Mea is an Associate Professor of Information Processing Systems at the University of Udine's Department of Mathematical, Computer and Physical Sciences. His research focuses on medical informatics, digital pathology, biomedical ontologies, and AI applications in healthcare. He holds abilitation to full professorship and is a member of the WHO Italian Collaborating Centre for International Classifications (WHO-FIC), ICHI Task Force, and ESDIP's Executive Board. He leads the EU MSCA Doctoral Network BosomShield (2022-2026) and previously managed the AIDPATH Marie Curie project. As an editor for journals like Digital Health and Journal of Pathology Informatics , he bridges academia and practice. Beyond academia, he is a poet with awards, including the Nelle terre dei Pallavicino Prize for his 2004 collection Algoritmi , and organizes interdisciplinary events merging science and literature. Education & Roles : Holds a professorship in Computer Science and teaches courses on web technologies, medical informatics, and AI across multiple degree programs. Previously served as Vice-President of SIBIM (Italian Biomedical Informatics Society). Research Interests : Specializes in digital pathology, medical AI, telemedicine, and standardization of health classifications like ICD-11 and ICF. His work emphasizes ontology harmonization and machine learning for clinical decision support. Recent Contributions : Published on WHO classification harmonization, AI-driven pathology tools, and energy-sector LLM applications. Active in editorial roles and international collaborations, including the HEROHE Challenge for breast cancer analysis. Awards & Recognition : 2023 – Poetry collection Clone 2.0 (neurally generated) 2005 – Nelle terre dei Pallavicino Award Grants & Projects : Led EU-funded projects (AIDPATH, BosomShield) and contributed to initiatives like the ICD-11 Mortality Coding System. Collaborates with institutions like AcegasApsAmga on AI for utilities. Labs & Initiatives : Involved in digital pathology workflow optimization and educational platforms for medical coding and AI ethics.

Steven Ramanمشاهده پروفایل

استاد بالینی

• MRI Imaging of Prostate Cancer
• Liver and Kidney Cancer Imaging
• Gynecological Cancers Imaging
• +۷ مورد دیگر

Dr. Steven Raman is a Clinical Professor in the Department of Radiological Sciences at the David Geffen School of Medicine, University of California, Los Angeles (UCLA). He serves as Director of Prostate MR Imaging and Interventions, Director of the UCLA Prostate MR Imaging Research Group, Director of the Abdominal Imaging Fellowship at UCLA, and Co-director of the Fibroid Treatment Program. Dr. Raman is an expert in Abdominal and Pelvic imaging (CT, MRI, Ultrasound and X-Ray) and interventional radiology, particularly in tumor ablation and Fibroid Treatment. Dr. Raman received his MD from Keck School of Medicine of the USC in 1993. He completed his Internship in Internal Medicine at Pacific Presbyterian Medical Center in 1994, Residency in Radiological Sciences at UCSD School of Medicine in 1998, and Fellowship in Abdominal Imaging at UCLA Department of Radiology in 1999. He is board certified in Diagnostic Radiology by the American Board of Radiology since 1998. His research focuses on MRI Imaging of Prostate, Liver, Kidney and Gynecological Cancers, Thermal Ablation techniques including microwave, cryo, HIFU and Irreversible Electroporation, and the application of Artificial Intelligence in Radiogenomics. His clinical expertise spans advanced imaging techniques with minimally invasive treatments for various cancers and conditions, with particular emphasis on prostate cancer diagnosis and treatment. Dr. Raman's publication record demonstrates a strong focus on cancer imaging and treatment across multiple organ systems. His work consistently bridges advanced imaging techniques with clinical applications, particularly in prostate cancer where he has contributed significantly to MR-guided biopsy techniques, image-pathology correlation, and surgical planning. His recent work increasingly incorporates AI applications for cancer detection. Super Doctors® Southern California, 2023-2025 Top Doctors, Los Angeles Magazine, 2021 Best Doctor, 2021 Super Doctors® Southern California, 2017-2021 Leading Physicians of the World, 2021 As Director of the Abdominal Imaging Fellowship at UCLA, Dr. Raman mentors radiology fellows in advanced imaging techniques and interventional procedures. His research group focuses on developing AI to better detect aggressive prostate cancer, with recent funding of $3 million for this purpose. His clinical work at the Westwood Imaging Center focuses on minimally invasive treatments for prostate cancer, liver diseases, and fibroid treatment, with particular expertise in image-guided thermal ablation therapies. Dr. Raman leads comprehensive clinical programs including the UCLA Uterine Fibroid Program and Fibroid Treatment Program, providing state-of-the-art care for women with uterine fibroids. His work on percutaneous image-guided thermal ablation for metastatic gynecologic cancers has been recognized as safe and effective therapy, demonstrating his commitment to advancing minimally invasive treatment options.

• Prostate Cancer
• Magnetic Resonance Imaging
• Artificial Intelligence in Medical Imaging
• +۵ مورد دیگر

Ivo Schoots is a Researcher at Erasmus MC in the Radiology & Nuclear Medicine department. His work focuses on prostate cancer , magnetic resonance imaging (MRI) , and artificial intelligence applications in medical imaging . Recent research trends include: AI-driven MRI reconstruction for cancer screening Comparative analysis of AI vs manual prostate cancer detection Radiomics for Gleason score differentiation Standardization of PI-RADS protocols Meta-analytic approaches to biopsy techniques

Lisa Adamsمشاهده پروفایل

پژوهشگر ارشد

• Artificial Intelligence in Radiology
• Quantitative Imaging Biomarkers
• Oncological Imaging
• +۵ مورد دیگر

Dr. Lisa Adams is a Research Fellow at the Technical University of Munich (TUM) and an Attending Radiologist at TUM University Hospital Rechts der Isar, affiliated with the Diagnostic and Interventional Radiology department. She holds an Albrecht Struppler Clinician Scientist Fellowship (2024) and leads research in the Quantitative Imaging Biomarkers for Predictive Healthcare focus group. Adams earned her MD from Charité - Universitätsmedizin Berlin (2016), completed board certification in radiology (2021), and conducted postdoctoral research at Stanford University (2022-2023). She transferred her Habilitation in Experimental Radiology to TUM in 2024. Her research integrates AI with radiology diagnostics, specializing in: Developing machine learning methods for early disease detection and risk assessment Advancing quantitative imaging biomarkers across organ systems Body composition analysis and biological age estimation Multimodal analysis for personalized healthcare Ethical implementation of AI in clinical practice Adams' recent publications demonstrate strong focus on AI applications in radiology, spanning large language models for clinical reporting, deep learning for medical image interpretation, nanoparticle tracking in regenerative medicine, and radiomics for cancer diagnosis. Her work consistently bridges technical innovation with clinical translation. Awards & Recognition: Walter-Friedrich-Prize, Deutsche Röntgengesellschaft (2023) Alavi Mandell Award (2021) Invest in the Youth Stipend, ECR Vienna (2017) She actively mentors doctoral candidates, having supervised seven PhD students to completion since 2020 with two more nearing submission. Adams secures substantial research funding from DFG, EU, Wilhelm Sander Foundation, Bayern Innovativ, and Berlin Institute of Health. She serves as Scientific Editor for European Radiology and Trainee Editorial Board Member for Radiology: Artificial Intelligence , while also holding leadership positions in the German Radiological Society.

Jonathan B. Bloomمشاهده پروفایل

دانشیار بالینی

• Urologic Oncology
• Prostate Cancer
• Kidney Stone Disease
• +۴ مورد دیگر

Dr. Jonathan B. Bloom is a UR Medicine Faculty member and an Associate Professor of Clinical Urology at the University of Rochester School of Medicine and Dentistry. He specializes in urologic oncology , particularly prostate cancer , with expertise in molecular imaging , MRI-US fusion biopsies , active surveillance , and focal therapy . His clinical work also includes kidney stone disease and benign prostate hypertrophy . Fellowship: Urologic Oncology, National Cancer Institute/National Institute of Health (2017-2019) Residency: Urology, New York Medical College (2013-2017) Internship: General Surgery, New York Medical College (2012-2013) MD: SUNY Downstate Medical Center College of Nursing (2012) Dr. Bloom's research focuses on prostate cancer imaging , advanced diagnostic techniques , and surgical outcomes . He has contributed extensively to studies on MRI-US fusion biopsies , robotic surgery , and patient safety . His work bridges clinical practice with technological innovation in urology. His publications highlight advancements in prostate cancer diagnosis , kidney stone management , and imaging-guided oncology . Key themes include minimally invasive techniques , cross-sectional imaging , and active surveillance applications. Subfields span metastatic mapping , radiological classification , and image-guided monitoring . Scientific Awards Alpha Omega Alpha medical honor society inductee Dr. Bloom has authored/co-authored over 26 peer-reviewed articles and contributed to textbooks on prostate cancer imaging and urothelial malignancies . His patient-centered approach is reflected in high satisfaction scores (4.8/5 stars) and testimonials praising his bedside manner and technical expertise .

Thomas E. Ahleringمشاهده پروفایل

استاد

• Urologic Oncology
• Robotic Surgery
• Prostate Cancer
• +۷ مورد دیگر

Dr. Thomas E. Ahlering is a Professor and Vice Chairman in the Department of Urology at the University of California, Irvine (UCI) School of Medicine. He is a leading expert in urologic oncology, specializing in robotic radical prostatectomy for prostate cancer, with over 2,500 surgeries performed. He previously served as Chief of Urologic Oncology at City of Hope and Chief of Urology at UC Irvine. His clinical and research work has earned him recognition as one of America’s Best Doctors since 1994 and as a Top 2% Medical Scientist globally. Dr. Ahlering's research interests center on urologic oncology , particularly robotic surgery , functional recovery after prostatectomy , and patient-reported outcomes . He has pioneered techniques in nerve-sparing and urinary anastomosis to improve continence and potency. His work has significantly contributed to the adoption and refinement of da Vinci robotic systems in urologic surgery. His scholarly output includes over 400 publications, with recent work focusing on surgical innovation, international training, patient selection, and long-term oncological outcomes. The articles reflect a strong emphasis on improving surgical precision, minimizing complications, and enhancing quality of life. Themes include technological evolution, global dissemination of robotic techniques, and patient-centered care. Scientific recognition includes: Lifetime Achievement Award in Robotic Surgery (North American Robotic Urology Symposium) Outstanding Faculty Achievement – Lauds and Laurels (UCI Alumni Association) Mentor of the Year (UCI Institute of Clinical and Translational Science) Top 2% of Medical Scientists in the World (Stanford Study) Consistently listed in America’s Best Doctors since 1994 Dr. Ahlering has mentored numerous trainees and residents, contributing significantly to education in urologic oncology. His lab and surgical team, often referred to as "The A-Team," operate at MiVIP Surgical Center and are known for their high coordination, patient-centered approach, and expertise in robotic prostatectomy. He continues to lead innovation in urinary diversion techniques such as the Indiana pouch and ileal neobladder.

Gary M. Hollenbergمشاهده پروفایل

استاد بالینی

• Radiology
• Medical Imaging
• Musculoskeletal MRI
• +۴ مورد دیگر

Gary M. Hollenberg, M.D. serves as a Professor of Clinical Imaging Sciences at the University of Rochester School of Medicine and Dentistry within the Department of Imaging Sciences. He is a key member of both the University of Rochester Medical Faculty Group (URMFG) and Accountable Health Partners (AHP), specializing in Body and Musculoskeletal MRI and Cross-Sectional Imaging with over 16 years of clinical experience in diagnostic radiology. His educational foundation includes a Medical Doctorate from the University of Rochester School of Medicine and Dentistry (1990), followed by an Internship in Internal Medicine at Highland Hospital of Rochester (1990-1991), a Radiology Residency at Rochester General Hospital (1991-1995), and a Cross-Sectional Imaging Fellowship at the University of Rochester Medical Center (1995-1996). He maintains active certification from the American Board of Radiology in Diagnostic Radiology. Dr. Hollenberg's research program bridges musculoskeletal radiology and prostate oncology imaging. Early career work established him in spinal MRI classification systems and tendon ultrasound diagnostics, while recent publications demonstrate a strategic pivot toward advanced prostate cancer imaging. His investigations focus on correlating MRI findings with clinical outcomes, particularly in developing quantitative biomarkers for prostate cancer detection and refining MR/US fusion biopsy techniques to guide treatment decisions in urology. Analysis of his 15 most recent publications (2000-2025) reveals a distinct trajectory: foundational musculoskeletal studies (2000-2003) centered on spine/wrist imaging and tendon pathologies have transitioned to a dominant prostate cancer focus (2016-2025). This evolution reflects growing clinical demand for precision imaging in urologic oncology, with his work increasingly appearing in high-impact urology journals while maintaining methodological roots in advanced MRI techniques. His scientific recognition includes: PROSE Award for publishing excellence (2016) Election as Fellow of the American College of Radiology (2014) NIH Summer Research Fellowship during medical training (1987-1988) Dr. Hollenberg contributes to academic medicine through editorial service on The Journal of The University of Rochester Medical Center (1989-1990) and as a Medical Student Interviewer for admissions (1988-1990). His research funding includes the Department of Radiology Fischer fund as co-investigator for Doppler sonography of the patellar tendon (2000-2001), demonstrating sustained grant acquisition capability across both musculoskeletal and prostate imaging domains. Professionally, he maintains active leadership through the Rochester Roentgen Ray Society (serving as past president) and membership in major national societies including the American College of Radiology, Radiological Society of North America, American Roentgen Ray Society, New York State Radiological Society, and Society of Skeletal Radiology. These affiliations facilitate multidisciplinary collaborations that drive innovation in imaging science and clinical application.

Keriayn Smithمشاهده پروفایل

دانشیار

• Non-coding RNA
• Genetics
• Epigenetics
• +۴ مورد دیگر

Keriayn Smith, PhD, is an Associate Professor in the Department of Genetics at the University of North Carolina School of Medicine and holds a concurrent appointment as an Associate Professor in the School of Data Science and Society. Her research focuses on non-coding RNAs, particularly long noncoding RNAs (lncRNAs), exploring their roles in cell identity, developmental processes, and disease mechanisms. She has received significant grants, including an NSF award ($665,786) for studying lncRNA functions in yeast and mammalian cells, and a Hypothesis Fund Seed Grant for investigating noncoding RNAs' roles in cell identity. Dr. Smith’s work emphasizes translational applications, such as leveraging lncRNA insights for regenerative medicine and personalized therapies. She leads initiatives like the RNA Discovery Center at UNC Lineberger Comprehensive Cancer Center, promoting diversity in RNA research. Notably, she chairs the Society for Scientific Advancement (SOSA), advocating for STEM accessibility in underserved regions and underrepresented groups. Her grants include a UNC Idea Grant for studying the oncogenic role of lncRNA Cyrano in neuroblastoma and supplemental funding during the pandemic to explore lncRNA roles in stem cell maintenance. Recent articles highlight her contributions to understanding lncRNA networks, epigenetic regulation, and interdisciplinary collaborations in genomics. Awards include the Junior Faculty Development Award from the UNC Provost’s Office, recognizing her project on comparative transcriptomics in ozone-exposure models. Dr. Smith’s research bridges basic science with clinical impact, addressing systemic risks to health through innovative, high-risk projects.

Nicholas G. Nickolsمشاهده پروفایل

استادیار

• Prostate Cancer
• Radiation Oncology
• Chemical Biology
• +۳ مورد دیگر

Nicholas G. Nickols is an Assistant Professor in the Department of Radiation Oncology at the David Geffen School of Medicine, University of California, Los Angeles. He earned his MD at UCLA and PhD in Chemical Biology at Caltech, combining clinical and research expertise in prostate cancer and radiation oncology. Radiobiology Research: His work focuses on chemical biology approaches to enhance radiotherapy through DNA repair interference, overcoming treatment resistance, and developing sequence-specific DNA-binding molecules like pyrrole-imidazole polyamides that target transcription factors. Publications: His recent works explore PSMA PET/CT-guided salvage radiotherapy, stereotactic body radiation therapy (SBRT) for prostate cancer, and immunomodulatory effects of radiation. Key themes include precision imaging, tumor microenvironment dynamics, and molecular targeting. Awards: No specific scientific awards mentioned in the text. Education: MD - UCLA School of Medicine, 2009 PhD - California Institute of Technology, 2008 Radiation Oncology Residency - UCLA, 2014 Internal Medicine Internship - UC Irvine, 2010

Saeed Amalمشاهده پروفایل

استاد پژوهشی

• Artificial Intelligence
• Healthcare Applications
• Deep Learning
• +۷ مورد دیگر

Saeed Amal is an Assistant Research Professor at Northeastern University's College of Engineering and Department of Bioengineering. He leads the Amal Lab for Precision Medicine, focusing on AI-driven healthcare solutions. His primary affiliation is with Northeastern's Roux Institute and he holds academic leadership roles in cardiovascular and cancer research. Previously, he was a Postdoctoral Fellow at Stanford University School of Medicine and held industry roles as VP of R&D at Cardiacx Medical (cardiology startup) and Data Scientist positions at companies like General Electric and Dynamic Yield. Education: B.Sc. in Computer Science, Technion - Israel Institute of Technology (2005) M.Sc. in Computer Science (Information Retrieval), University of Haifa (2009) Ph.D. in Computer Science (Machine Learning), University of Haifa (2019) Postdoctoral Research, Stanford University (2021–Present) Research Interests: AI applications in healthcare, including deep learning for medical imaging, NLP for clinical text analysis, and multimodal data fusion for cardiovascular and cancer care. His work emphasizes precision medicine, automated disease diagnosis (e.g., prostate and breast cancer), and improving patient outcomes through AI-driven tools. Key Contributions: Developed AI tools for cardiovascular disease prediction using multimodal data fusion, led initiatives in digital pathology for cancer grading, and pioneered the use of generative AI in Gleason pattern segmentation. His lab has published extensively on machine learning models for adverse event prediction in surgery and healthcare decision-making visualization. Awards: Emerging Visionary Award (Northeastern University NAI, 2025) Grants and Collaborations: Partnered with Santovia Path AI and Prima CARE on AI tools for cancer diagnosis. His work is supported by Northeastern's research initiatives and collaborations with institutions like Stanford University School of Medicine. Labs/Teams: Director of The Amal Lab for Precision Medicine, focusing on AI and multimodal data integration for disease care.

• Prostate Cancer Treatment
• Minimally Invasive Robotic Surgery
• Treatment Resistance Mechanisms
• +۳ مورد دیگر

Dr. Isaac Y. Kim is a Professor and Chair of Urology at Yale School of Medicine, specializing in prostate cancer treatment with expertise in robotic surgery. He leads clinical and laboratory research on metastatic prostate cancer, focusing on surgical interventions and treatment resistance mechanisms. His clinical work includes over 2,400 robotic prostatectomies, emphasizing minimally invasive approaches. He is Principal Investigator of the SIMCAP trial evaluating cytoreductive prostatectomy in metastatic cases. Research interests include androgen receptor degradation via PROTAC technology. He holds an MD, PhD in Tumor Cell Biology, and an MBA in Finance. Active in education, he mentors trainees and improves urology residency programs. Clinical affiliations include Yale Medicine with locations in New Haven and beyond. Educations: MD (Northwestern 1997), PhD (Northwestern 1996), MBA (Wharton 2017) Research Labs: Cancer Signaling Networks at Yale Cancer Center Labs/Teams: Urologic Oncology Group, Prostate & Urologic Cancers Program Grants: Leading multi-institutional clinical trials Key collaborations include work with Michael Leapman, Preston Sprenkle, and Joshua Sterling. His work bridges surgery and molecular mechanisms to improve outcomes for advanced prostate cancer patients.